Drugs / porfimer sodium
last change Oct 2025 re-read 2 minutes ago

porfimer sodium

Small molecule

Developed for
non-small cell lung carcinoma · head and neck cancer · lung cancer · malignant mesothelioma · extrahepatic bile duct carcinoma · gallbladder cancer · pleural disorder · bile duct cancer
+25 more · brain cancer · central nervous system cancer · esophageal adenocarcinoma · esophageal cancer · esophageal squamous cell carcinoma · gallbladder carcinoma · head and neck carcinoma · hepatocellular carcinoma · hilar cholangiocarcinoma · larynx verrucous carcinoma · malignant glioma · malignant pancreatic neoplasm · metastatic malignant neoplasm · metastatic squamous cell carcinoma · obstructive jaundice · oropharynx squamous cell carcinoma · pancreatic acinar cell carcinoma · pancreatic ductal adenocarcinoma · pleural epithelioid mesothelioma · precancerous condition · small cell lung carcinoma · superficial urinary bladder carcinoma · tongue carcinoma · verrucous carcinoma of oral cavity · central nervous system neoplasm
Investigated by
Roswell Park Cancer Institute · National Cancer Institute (NCI) · Pinnacle Biologics Inc. · Concordia Laboratories Inc. · Abramson Cancer Center at Penn Medicine · Harry T Whelan, MD
+16 more · American Society for Gastrointestinal Endoscopy · Axcan Pharma · Colorado Health Foundation · John DeWitt · Jonsson Comprehensive Cancer Center · Lumeda,Inc. · Memorial Sloan Kettering Cancer Center · North Florida Foundation for Research and Education · North Florida/South Georgia Veterans Health System · Ohio State University Comprehensive Cancer Center · Samsung Medical Center · Simphotek Inc. · Taoyuan General Hospital · The First Affiliated Hospital of Henan University of Science and Technology · University College, London · University of Miami

Regulatory milestones approvals, filings & regulatory actions · 6 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Withdrawn EU (EMA) PhotoBarr 2012-04-20 europa.eu
Label expansions (3) US (FDA) PHOTOFRIN 1998-01-09 – 2008-09-08 fda.gov
Approved EU (EMA) PhotoBarr 2004-03-25 europa.eu
Approved US (FDA) PHOTOFRIN 1995-12-27 fda.gov

Trials 28 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04753918 Mar → Sep 2021 non-small cell lung carcinoma Taoyuan General Hospital Unknown No outcome recorded
Phase 18 trials
Phase 1 NCT04836429 Mar 2022 → Feb 2024 non-small cell lung carcinoma, pleural disorder Roswell Park Cancer Institute Terminated No outcome recorded
Phase 1 NCT03678350 Sep 2021 → Nov 2023 malignant mesothelioma, non-small cell lung carcinoma, pleural disorder Roswell Park Cancer Institute Completed No outcome recorded
Phase 1 NCT03727061 Jul 2019 → Oct 2024 head and neck carcinoma Roswell Park Cancer Institute Terminated No outcome recorded
Phase 1 NCT03344861 Aug 2017 → Mar 2019 lung cancer Concordia Laboratories Inc. Completed No outcome recorded
Phase 1 NCT02916745 Jan 2017 → Apr 2019 non-small cell lung carcinoma Concordia Laboratories Inc. Completed No outcome recorded
Phase 1 NCT01770132 Apr 2013 → Jul 2017 pancreatic acinar cell carcinoma, pancreatic ductal adenocarcinoma John DeWitt Completed No outcome recorded
Phase 1 NCT01682746 Mar 2013 → Jun 2018 brain cancer Harry T Whelan, MD Completed No outcome recorded
Phase 1 NCT00014066 Mar 1993 → Feb 2004 lung cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT03735095 Feb 2020 → Jul 2024 non-small cell lung carcinoma, small cell lung carcinoma Roswell Park Cancer Institute Completed No outcome recorded
Phase 1/2 NCT00322699 Feb 2005 → Apr 2010 superficial urinary bladder carcinoma North Florida/South Georgia Veterans Health System Completed No outcome recorded
Phase 29 trials
Phase 2 NCT01966809 Jun 2015 → Dec 2017 malignant glioma Harry T Whelan, MD Terminated No outcome recorded
Phase 2 NCT02153229 Jun 2014 → Dec 2026 expected pleural epithelioid mesothelioma Abramson Cancer Center at Penn Medicine Active not recruiting No outcome recorded
Phase 2 NCT02068157 Apr 2014 → Oct 2016 larynx verrucous carcinoma, metastatic squamous cell carcinoma, oropharynx squamous cell carcinoma, tongue carcinoma +1 Roswell Park Cancer Institute Terminated No outcome recorded
Phase 2 NCT00601848 Nov 2004 → Feb 2012 lung cancer, metastatic malignant neoplasm Abramson Cancer Center at Penn Medicine Terminated No outcome recorded
Phase 2 NCT00453336 Jun 2003 → Aug 2009 head and neck cancer, precancerous condition University of Miami Completed No outcome recorded
Phase 2 NCT00054002 Mar 1999 → Jun 2006 malignant mesothelioma Roswell Park Cancer Institute Completed No outcome recorded
Phase 2 NCT00003923 Mar 1999 → Feb 2002 extrahepatic bile duct carcinoma, gallbladder cancer, malignant pancreatic neoplasm Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 2 NCT00002935 Oct 1995 → Aug 2006 esophageal cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 2 NCT00002964 Feb 1995 → Apr 2004 head and neck cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 35 trials
Phase 3 NCT02628665 Oct 2015 → Oct 2017 esophageal adenocarcinoma, esophageal squamous cell carcinoma The First Affiliated Hospital of Henan University of Science and Technology Unknown No outcome recorded
Phase 3 NCT02082522 Nov 2014 → Jan 2017 hilar cholangiocarcinoma Concordia Laboratories Inc. Terminated No outcome recorded
Phase 3 NCT00513539 Jul 2007 → Dec 2009 bile duct cancer, gallbladder cancer University College, London Completed No outcome recorded
Phase 3 NCT00003788 Apr 1998 → ? central nervous system cancer Colorado Health Foundation Unknown No outcome recorded
Phase 3 NCT00253617 extrahepatic bile duct carcinoma, gallbladder carcinoma Jonsson Comprehensive Cancer Center Withdrawn No outcome recorded
Phase not applicable3 trials
NCT02106559 Sep 2014 → Jan 2016 malignant mesothelioma, non-small cell lung carcinoma Ohio State University Comprehensive Cancer Center Withdrawn No outcome recorded
NCT01506115 Sep 2009 → Mar 2011 hepatocellular carcinoma, obstructive jaundice Samsung Medical Center Completed No outcome recorded
NCT00530088 Oct 2001 → Aug 2010 head and neck cancer Roswell Park Cancer Institute Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00118222 Comparator Mar 2005 → Mar 2006 central nervous system neoplasm Case Comprehensive Cancer Center Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 30 sources stand behind the page.

FieldValueCited text
Known as porfimer sodium “Photodynamic therapy (PDT) is a combination of a drug, porfimer sodium (Photofrin), which is activated by a light from a laser that emits no heat.” NCT02082522
23

“Everyone in this study will receive Photofrin® (porfimer sodium) for injection (Pinnacle Biologics, Inc., Bannockburn, IL, USA)” NCT01966809

“Photofrin (porfimer sodium) photodynamic therapy.” NCT01682746

NCT02068157

NCT02916745

NCT03735095

NCT00002935

NCT03344861

NCT00002964

NCT00453336

NCT00003788

NCT04836429

NCT00601848

NCT01770132

NCT02106559

NCT00054002

NCT00003923

NCT03678350

NCT03727061

NCT04753918

NCT00253617

NCT00513539

NCT00118222

NCT00530088

Known as CL 184,116 ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Known as Photobarr ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Known as Photofrin “To determine the feasibility and toxicities of incorporating surgical resection and intra-operative Photofrin (porfimer sodium)-mediated photodynamic therapy in patients (pts)...” NCT02106559
11

“OBJECTIVES: I. Evaluate the efficacy of photodynamic therapy (PDT) using porfimer sodium (Photofrin) and controlled uniform laser light in patients with carcinoma in situ in...” NCT00002935

“Photodynamic therapy (PDT) is a combination of a drug, porfimer sodium (Photofrin), which is activated by a light from a laser that emits no heat.” NCT02082522

Photofrin solution is administered slowly as a bolus injection over 3-5 minutes on day 1.” NCT00014066

“Patients receive porfimer sodium (Photofrin) IV one day prior to surgery.” NCT00003788

“Patients receive porfimer sodium (Photofrin®) IV over 5-15 minutes.” NCT00601848

NCT01966809

NCT01506115

NCT02153229

NCT02628665

NCT00322699

NCT01682746

Known as Photofrin ii ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Known as Porfimere sodique ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Known as Porfimero de sodio ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Known as Profimer sodium ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481
Modality Other / unclassified “the photosensitizer prior to surgery” NCT02153229
Modality Small molecule CHEMBL1201481
Route Intravenous “PDT consists of IV porfimer sodium” NCT00002935